Laboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Laboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia; Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
J Ethnopharmacol. 2016 Jul 1;187:195-204. doi: 10.1016/j.jep.2016.04.048. Epub 2016 Apr 27.
Dillenia suffruticosa is traditionally used for treatment of cancerous growth including breast cancer in Malaysia.
Dillenia suffruticosa is a well-known medicinal plant in Malaysia for the treatment of cancer. Nevertheless, no study has been reported the cytotoxicity of this plant towards MDA-MB-231 triple-negative breast cancer cells. The present study was designed to investigate the mode of cell death and signalling pathways of MDA-MB-231 cells treated with dichloromethane Dillenia suffruticosa root extract (DCM-DS).
Extraction of Dillenia suffruticosa root was performed by the use of sequential solvent procedure. The cytotoxicity of DCM-DS was determined by using MTT assay. The mode of cell death was evaluated by using an inverted light microscope and flow cytometry analysis using Annexin-V/PI. Cell cycle analysis and measurement of reactive oxygen species level were performed by using flow cytometry. The cells were treated with DCM-DS and antioxidants α-tocopherol or ascorbic acid to evaluate the involvement of ROS in the cytotoxicity of DCM-DS. Effect of DCM-DS on the expression of antioxidant, apoptotic, growth, survival genes and proteins were analysed by using GeXP-based multiplex system and Western blot, respectively. The cytotoxicity of compounds isolated from DCM-DS was evaluated towards MDA-MB-231 cells using MTT assay.
DCM-DS induced apoptosis, G2/M phase cell cycle arrest and oxidative stress in MDA-MB-231 cells. The induction of apoptosis in MDA-MB-231 cells by DCM-DS is possibly due to the activation of pro-apoptotic JNK1 and down-regulation of anti-apoptotic ERK1, which in turn down-regulates anti-apoptotic BCL-2 to increase the BAX/BCL-2 ratio to initiate the mitochondrial apoptotic pathway. The cell cycle arrest in DCM-DS-treated MDA-MB-231 cells is possibly via p53-independent but p21-dependent pathway. A total of 3 triterpene compounds were isolated from DCM-DS. Betulinic acid appears to be the most major and most cytotoxic compound in DCM-DS.
The data suggest the potential application of DCM-DS in the treatment of triple-negative breast cancer.
在马来西亚,杜茎山被传统用于治疗包括乳腺癌在内的癌性生长。
杜茎山是马来西亚一种著名的药用植物,用于治疗癌症。然而,目前尚无研究报道该植物对 MDA-MB-231 三阴性乳腺癌细胞的细胞毒性。本研究旨在探讨二氯甲烷杜茎山根提取物(DCM-DS)处理 MDA-MB-231 细胞的细胞死亡方式和信号通路。
采用连续溶剂法提取杜茎山根。用 MTT 法测定 DCM-DS 的细胞毒性。用倒置显微镜和 Annexin-V/PI 流式细胞术分析评估细胞死亡方式。用流式细胞术进行细胞周期分析和活性氧(ROS)水平测定。用 DCM-DS 和抗氧化剂α-生育酚或抗坏血酸处理细胞,以评估 ROS 在 DCM-DS 细胞毒性中的作用。用 GeXP 多重系统和 Western blot 分别分析 DCM-DS 对抗氧化、凋亡、生长、存活基因和蛋白表达的影响。用 MTT 法评价从 DCM-DS 中分离得到的化合物对 MDA-MB-231 细胞的细胞毒性。
DCM-DS 诱导 MDA-MB-231 细胞凋亡、G2/M 期细胞周期阻滞和氧化应激。DCM-DS 诱导 MDA-MB-231 细胞凋亡可能是通过激活促凋亡 JNK1 和下调抗凋亡 ERK1,从而下调抗凋亡 BCL-2 增加 BAX/BCL-2 比值启动线粒体凋亡途径。DCM-DS 处理的 MDA-MB-231 细胞的细胞周期阻滞可能是通过 p53 非依赖性但 p21 依赖性途径。从 DCM-DS 中分离得到 3 种三萜类化合物。白桦脂酸似乎是 DCM-DS 中最主要和最具细胞毒性的化合物。
数据表明 DCM-DS 具有治疗三阴性乳腺癌的应用潜力。